Jinyu Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jinyu Wang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Dan Tong
Changping Laboratory, Beijing, China
10 shared publications - Guohui Dang
Changping Laboratory, Beijing, China
10 shared publications - Lu Qi
Changping Laboratory, Beijing, China
10 shared publications - Sijin Cheng
Institute for Data-Driven Tumor Immunology, Chongqing Medical University, Chongqing 400016, China
10 shared publications - Tianyi Ma
Division of Life Sciences and Medicine, University of Science and Technology of China, hefei, China
10 shared publications - Wenbin Xu
State Key Laboratory of Common Mechanism Research for Major Diseases & Department of Medical Genetics, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
10 shared publications
Latest Publications
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Supplementary Figure S1. Dataset statistics and annotation workflow, related to Figure 1.
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Supplementary Figure S1. Dataset statistics and annotation workflow, related to Figure 1.
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Supplementary Figure S2. Transcriptional characteristics of different DC subsets, related to Figure 1.
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Supplementary Figure S2. Transcriptional characteristics of different DC subsets, related to Figure 1.
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Supplementary Figure S5. Characteristics of LAMP3+ DC and performance of our prediction model, related to Figures 5 and 6.
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Supplementary Figure S5. Characteristics of LAMP3+ DC and performance of our prediction model, related to Figures 5 and 6.
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Supplementary Figure S3. Characteristics and tissue distribution of cDC2 subsets, related to Figure 2.
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Supplementary Figure S3. Characteristics and tissue distribution of cDC2 subsets, related to Figure 2.
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Supplementary Figure S4. Characteristics of AS DC and LC-like subsets, related to Figures 3 and 4.
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Supplementary Figure S4. Characteristics of AS DC and LC-like subsets, related to Figures 3 and 4.
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Supplementary Figure S6. Performance of our prediction model, related to Figure 6.
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Supplementary Figure S6. Performance of our prediction model, related to Figure 6.
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Supplementary Figure S7. Dissecting the heterogeneity of cDC1s, related to Discussion.
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Supplementary Figure S7. Dissecting the heterogeneity of cDC1s, related to Discussion.
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Tables from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Supplementary Tables Supplementary Table S1. Summary statistics of scRNA-seq datasets collected in this study. Supplementary Table S2. DEGs for 10 DC subsets. Supplementary Table S3. DEGs for seven cDC2 subsets. Supplementary Table S4. DEGs for LC-like subsets from non-cutaneous tumor tissues, cutaneous tumor tissues and normal skin. Supplementary Table S5. Gene sets used in this study. Supplementary Table S6. P values related to Fig. 2A, 3A, 4A, 4D and Supplementary Fig. S4I.
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Supplementary Tables Supplementary Table S1. Summary statistics of scRNA-seq datasets collected in this study. Supplementary Table S2. DEGs for 10 DC subsets. Supplementary Table S3. DEGs for seven cDC2 subsets. Supplementary Table S4. DEGs for LC-like subsets from non-cutaneous tumor tissues, cutaneous tumor tissues and normal skin. Supplementary Table S5. Gene sets used in this study. Supplementary Table S6. P values related to Fig. 2A, 3A, 4A, 4D and Supplementary Fig. S4I.
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Data from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Dendritic cells (DC) are pivotal orchestrators of antitumor immunity. DC-based antitumor treatments are being actively developed, but effective clinical responses have not yet been achieved. Further exploration of DC heterogeneity in the tumor microenvironment and across cancer types could provide insights for developing DC-based immunotherapies. In this study, we integrated single-cell RNA sequencing data of DCs from more than 2,500 samples across 33 cancer types and established a comprehensive blueprint of human DCs. Several rare subsets of DCs infiltrated the tumors, including AXL+SIGLEC6+ DCs and Langerhans cell–like DCs, and displayed functional potentials marked with distinct transcriptomic characteristics. Computational analyses demonstrated that the Langerhans cell–like subset could be an additional cellular origin of tumor-enriched LAMP3+ DCs and that distinct cellular origins are associated with the pleiotropic functional potentials of LAMP3+ DCs. Furthermore, this DC atlas enabled the development of a machine learning model to guide DC annotation for subsequent single-cell analysis and prioritization of a valuable target for enhancing antitumor DC vaccination. This integrative resource provides a panoramic view to unravel the complexity of tumor-infiltrating DCs and offers valuable insights for developing therapies targeting DCs.Significance:The comprehensive dissection of tumor-infiltrating dendritic cells redefined cell subsets with different regulations, tissue preferences, and functional potentials and provided an atlas as a rich resource with promising applications.This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI.
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Dendritic cells (DC) are pivotal orchestrators of antitumor immunity. DC-based antitumor treatments are being actively developed, but effective clinical responses have not yet been achieved. Further exploration of DC heterogeneity in the tumor microenvironment and across cancer types could provide insights for developing DC-based immunotherapies. In this study, we integrated single-cell RNA sequencing data of DCs from more than 2,500 samples across 33 cancer types and established a comprehensive blueprint of human DCs. Several rare subsets of DCs infiltrated the tumors, including AXL+SIGLEC6+ DCs and Langerhans cell–like DCs, and displayed functional potentials marked with distinct transcriptomic characteristics. Computational analyses demonstrated that the Langerhans cell–like subset could be an additional cellular origin of tumor-enriched LAMP3+ DCs and that distinct cellular origins are associated with the pleiotropic functional potentials of LAMP3+ DCs. Furthermore, this DC atlas enabled the development of a machine learning model to guide DC annotation for subsequent single-cell analysis and prioritization of a valuable target for enhancing antitumor DC vaccination. This integrative resource provides a panoramic view to unravel the complexity of tumor-infiltrating DCs and offers valuable insights for developing therapies targeting DCs.Significance:The comprehensive dissection of tumor-infiltrating dendritic cells redefined cell subsets with different regulations, tissue preferences, and functional potentials and provided an atlas as a rich resource with promising applications.This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI.
- Open Access
- 31 July 2025
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 85 (19) , 3596-3613
Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Dendritic cells (DC) are pivotal orchestrators of antitumor immunity. DC-based antitumor treatments are being actively developed, but effective clinical responses have not yet been achieved. Further exploration of DC heterogeneity in the tumor microenvironment and across cancer types could provide insights for developing DC-based immunotherapies. In this study, we integrated single-cell RNA sequencing data of DCs from more than 2,500 samples across 33 cancer types and established a comprehensive blueprint of human DCs. Several rare subsets of DCs infiltrated the tumors, including AXL+SIGLEC6+ DCs and Langerhans cell–like DCs, and displayed functional potentials marked with distinct transcriptomic characteristics. Computational analyses demonstrated that the Langerhans cell–like subset could be an additional cellular origin of tumor-enriched LAMP3+ DCs and that distinct cellular origins are associated with the pleiotropic functional potentials of LAMP3+ DCs. Furthermore, this DC atlas enabled the development of a machine learning model to guide DC annotation for subsequent single-cell analysis and prioritization of a valuable target for enhancing antitumor DC vaccination. This integrative resource provides a panoramic view to unravel the complexity of tumor-infiltrating DCs and offers valuable insights for developing therapies targeting DCs. Significance: The comprehensive dissection of tumor-infiltrating dendritic cells redefined cell subsets with different regulations, tissue preferences, and functional potentials and provided an atlas as a rich resource with promising applications. This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI.
- 31 July 2025
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 85 (19) , 3596-3613
Open AccessPan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells
Dendritic cells (DC) are pivotal orchestrators of antitumor immunity. DC-based antitumor treatments are being actively developed, but effective clinical responses have not yet been achieved. Further exploration of DC heterogeneity in the tumor microenvironment and across cancer types could provide insights for developing DC-based immunotherapies. In this study, we integrated single-cell RNA sequencing data of DCs from more than 2,500 samples across 33 cancer types and established a comprehensive blueprint of human DCs. Several rare subsets of DCs infiltrated the tumors, including AXL+SIGLEC6+ DCs and Langerhans cell–like DCs, and displayed functional potentials marked with distinct transcriptomic characteristics. Computational analyses demonstrated that the Langerhans cell–like subset could be an additional cellular origin of tumor-enriched LAMP3+ DCs and that distinct cellular origins are associated with the pleiotropic functional potentials of LAMP3+ DCs. Furthermore, this DC atlas enabled the development of a machine learning model to guide DC annotation for subsequent single-cell analysis and prioritization of a valuable target for enhancing antitumor DC vaccination. This integrative resource provides a panoramic view to unravel the complexity of tumor-infiltrating DCs and offers valuable insights for developing therapies targeting DCs. Significance: The comprehensive dissection of tumor-infiltrating dendritic cells redefined cell subsets with different regulations, tissue preferences, and functional potentials and provided an atlas as a rich resource with promising applications. This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI.